Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (421-430 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|May 10, 2002
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary SyndromesW B Batchelor, C B Granger, N S Kleiman, et al.
Circulation|April 1, 1995
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II InvestigatorsD R Holmes, E J Topol, R M Califf, et al.
The American Journal of Cardiology|January 1, 1990
Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill testJ R Bengtson, D B Mark, M B Honan, et al.
Lancet (London, England)|January 15, 2000
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingE J Topol, D B Mark, A M Lincoff, et al.
Journal of the American College of Cardiology|November 30, 1999
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI)P L Whitlow, A P Dimas, T M Bashore, et al.
Circulation|November 1, 1987
The changing survival benefits of coronary revascularization over timeD B Pryor, F E Harrell, J S Rankin, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
The American Journal of Cardiology|July 1, 1991
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectorisJ D Jackman, F I Navetta, J E Smith, et al.
Circulation|February 1, 1983
Outcome in one-vessel coronary artery diseaseR M Califf, Y Tomabechi, K L Lee, et al.
Circulation|March 1, 1996
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trialC B Granger, J Hirsch, R M Califf, et al.
Pageof 57

Showing results (421-430 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|May 10, 2002
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary SyndromesW B Batchelor, C B Granger, N S Kleiman, et al.
Circulation|April 1, 1995
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II InvestigatorsD R Holmes, E J Topol, R M Califf, et al.
The American Journal of Cardiology|January 1, 1990
Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill testJ R Bengtson, D B Mark, M B Honan, et al.
Lancet (London, England)|January 15, 2000
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingE J Topol, D B Mark, A M Lincoff, et al.
Journal of the American College of Cardiology|November 30, 1999
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI)P L Whitlow, A P Dimas, T M Bashore, et al.
Circulation|November 1, 1987
The changing survival benefits of coronary revascularization over timeD B Pryor, F E Harrell, J S Rankin, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
The American Journal of Cardiology|July 1, 1991
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectorisJ D Jackman, F I Navetta, J E Smith, et al.
Circulation|February 1, 1983
Outcome in one-vessel coronary artery diseaseR M Califf, Y Tomabechi, K L Lee, et al.
Circulation|March 1, 1996
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trialC B Granger, J Hirsch, R M Califf, et al.
Pageof 57